glp-1 antibody GLP-1R Suitable for ICC/IF Anti-GLP-1 antibody [11E2]

An alternative that achieves similar weight loss but with fewer gastrointestinal side effects or different tolerability characteristics may actually be preferable, even if the mechanism differs

0+1 GlutathioneGSH [1] 307.325 g/mol189193 C [2] -SH [3] G-SHG-S-S-G [4] NADPHR-SH0.510 mmol/L GSHGSSG1001GSH371mg L-1 [5] glutathione [6] GSH [7] [7] [7] CAS 70-18-8 PubChem 745-124886 C10H17N3O6S 307.325g/mol 189 193 1001000 mg/100 g [8] 26-34 mg/100 g58-73 mg/100g10-15 mg/100 g12-33 mg/100 g0.06-0.7 mg/100 g [1] 70 mg/100 [9] GPxH2O2H2OGSSGGSHCE [10] -S-GSTGSH NKNF-B [11] GSHGSH GSHSH-GSH-SHHaddadGSHI-KB/NF-KBArmstrongGSH [12] [13] [14] [15-16] [17] [18-19] [20] DTNBEllmanHPLCGSH [21] DTNB DTNB5--2-412 nmDTNB400 nmDTNB412 nm [21] 1DTNB0.01 mol/LDTNB0.05 mol/LpH7.0DTNB 2DTNBDTNB0.5 mol/LpH8.0Tris - HCl100DTNB 30.1 ~ 3.0 mol/L0.5 mL1.5 mL0.15 mol/LNaOH3%05mLpH8.0252 min0.5 mLDTNB255 min412 nm [21] 0.05 mg10 mL2%HPO3100 mL100 mL5 mL100 mL 2% HPO35 mL10 mL5%1 mL20.001 mol/L0.001 mol/L2.445 mL100% V-0.001 mol/LmL2.445 -100%mL [21] Kromasil C184.6 mm 250 mm5 m 3.0 g1.0 g500 mLpH3 = 964 210 nm0.8 mL/min3010 L 25 g/mL50 g/mL100 Vg/mL200 g/mL400 g/mL800 g/mL 25 ~ 800 g/mL 10 L0.9995 10 L 0.1 g0.3 g0.6 g SH [22] [22] 30.4 g4121 1 [22] 1500 mg/m2100 ml5%152 ~ 5600 mg1535mg/mg [22] 2 1200 mg1/301200 ~ 2400 mg1/301200mg1/301800 mg1/301800 mg1/14 ~ 301200 ~ 1800 mg1/14 ~ 30 [22] 31500 mg/m2 4500 mg/m100 ml300 ~ 600mg 5300600 mg20 ml 1 [22] 2 3 1 [22] 2 3 4 5

Protein consumption should be individually tailored to the patients needs

Coelho et al., 2014

Spontaneous modulation of granulomatous hypersensitivity in Schistosomiasis mansoni

GnRH antagonists block GnRH signaling to the pituitary preventing the release of LH and be used in shorter, patient friendly IVF cycles with less side effects